Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma (Q57522088)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

N Himoudi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

R Wallace

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

K L Parsley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

K Gilmour

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

A-U Barrie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

K Howe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

R Dong

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

A Michalski

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

A J Thrasher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

J Anderson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

271-279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Therapeutic dendritic cell vaccination of patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Nonresectable multiple lung metastases of high-grade osteosarcoma of the humerus: stable after twelve years. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Immunotherapy with autologous dendritic cells and tumor-specific synthetic peptides for synovial sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0795-1

Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.

21 January 2018

1 reference

12 December 2020

Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours

1 reference

12 December 2020

Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

10.1007/S12094-012-0795-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference